On 11 March 2020, the World Health Organization declared COVID-19 a pandemic. The impact on the medical community has been huge, not only on the front-line but also for patients navigating treatment for cardiology conditions during this unprecedented situation.
The touchCARDIO expert faculty have been sharing their experiences and advice during this challenging time through video interviews and short articles.
The HEP-COVID Trial
In an expert interview, Dr Alex Spyropoulos, who designed and led this study, discusses the study aims, design and findings, which have led to a paradigm shift in the care of high-risk hospitalized patients with COVID-19.
The impact of COVID-19 on AF detection
Trudie Lobban MBE (CEO and Trustee, A-A, AF Association & STARS) talks about the impact of COVID-19 on AF detection in the community, and the importance of seeking advice for people who notice an irregular heartbeat.
AF Symposium 2021: Atrial Fibrillation in the Post-COVID-19 Environment
We spoke to Dr Suneet Mittal (Director of Electrophysiology, The Valley Hospital, Ridgewood, NJ, USA) about the workflow innovations for atrial fibrillation ablation in the post-COVID-19 environment
Findings from the WASE COVID study
Federico Asch (MedStar Health Research Institute, Columbia, MD, USA) discusses the findings of the WASE COVID study, presented at ACC 2021. The study compared AI software-based echocardiography analysis with manual expert analysis to predict mortality based on longitudinal strain and LVEF.
COVID-19 and Cardiac Arrhythmias
European Journal of Arrhythmia & Electrophysiology. 2021;7(1):33-39 DOI: https://doi.org/10.17925/EJAE.2021.7.1.33
Obesity and COVID-19
Dr Ali Aminian(Director, Bariatric and Metabolic Institute, Cleveland Clinic, Cleveland, OH, USA) kindly shared his thoughts on the association between obesity and COVID-19 and the results of his study on the association of prior metabolic surgery and bariatric surgery with COVID-19 severity from the virtual ESC Congress 2021.
Cardiometabolic Risk Factors and COVID-19
Dr Darryl Leong (Cardiologist, The Population Health Research Institute, McMaster University, Hamilton, ON, Canada) kindly shared his thoughts on the association between cardiometabolic risk factors and COVID-19 outcomes from the virtual ESC Congress 2021.
What have cardiologists learned from COVID-19?
touchCARDIOLOGY speaks to Dr Gustavo Samaja (Chief of Interventional Cardiology, Policlinico Bancario Argentina) to find out how the government are managing the spread of the COVID-19 virus in Argentina and the effect the pandemic has had on cardiologists, treatment plans and clinical practice
96/Impact of COVID-19 on ventricular tachycardia and atrial tachycardia events in patients with transvenous devices
Heart International. 2020;14(1):16–9 DOI: https://doi.org/10.17925/HI.2020.14.1.16.
Cardiovascular Effects of COVID-19 – What Do We Know and Where Should We Go?
Heart International. 2020;14(1):16–9 DOI: https://doi.org/10.17925/HI.2020.14.1.16
12/Comparisons of patient management in the COVID era, the patient’s perspective
European Journal of Arrhythmia & Electrophysiology. 2020;6(Suppl. 1):abstr12
Education activities are developed by touchIME for touchCARDIO.
Our education resources are developed in collaboration with our well established peer-reviewed medical journals, our Editorial Board members and partnerships with major medical societies, with a clear commitment to high-quality independent education.
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!